Immunization Information Systems: A Key Enabler of Life Course Immunization, Health Equity, and Healthy Aging Across the Globe

On October 14, 2024, alongside the World Health Summit in Berlin, Germany and Silver Economy Forum 2024, the Global Coalition on Aging (GCOA) convened a cross-disciplinary group of experts and leaders in Immunization Information Systems (IIS) across development, implementation, and advocacy from a diverse geographical scope, together with experts in healthy aging and policy.  Experts discussed the best practices and successful IIS, challenges, and barriers, as well as the advocacy needs for IIS as a critical public health tool to advance life course immunization, health equity, and more resilient health systems in the face of global demographic change. 

This new GCOA report distills four key takeaways and four calls to action from the roundtable discussion: 

  1. IIS are fundamental to increasing vaccine coverage rates, supporting evidence-based decision-making, and enabling informed immunization policies across the life course.
  2. The COVID-19 pandemic underscored the urgent need for effective IIS, revealing gaps in digital infrastructure and interoperability that hinder both routine and emergency immunization efforts. 
  3. Building vaccine confidence and public trust in data privacy is critical to IIS success; meaningful engagement with healthcare providers and the public is essential. 
  4. IIS require more than technical solutions—alignment and advocacy across stakeholders, from policymakers to the public, are necessary to realize their full value and drive system-wide improvements. 

The report highlights persistent data gaps, especially in adult immunization, and the need for countries to strengthen, expand, and connect their IIS to support healthy aging and resilient health systems. It calls for bold, coordinated action to prioritize IIS development, communicate IIS value, and ensure that no one is left behind in the global effort to prevent disease and promote healthy longevity. 

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.

New Report From the Global Coalition on Aging Highlights the Connection Between Adult Immunization and Economic Health in Aging APEC Region

As leaders from across the Asia-Pacific Economic Cooperation (APEC) region convene in San Francisco over the next week, a new report from the Global Coalition on Aging (GCOA) points to investments in healthy aging as a growing economic imperative amid the region’s changing demographics. According to the new report, programs that keep populations healthy, active, and productive – like adult immunization – are increasingly becoming a prerequisite for economic stability and growth.